Genetic testing for kidney disease risk in African Americans

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates the prevalence of APOL1 renal risk variants among African American patients with hypertension at Saint Louis University. It aims to understand how knowledge of one's APOL1 genotype influences patient engagement in managing hypertension and other renal risk factors. Participants will complete self-administered surveys to express their attitudes towards genetic testing and its implications for kidney health. The study seeks to bridge the gap between genetic predisposition and clinical outcomes in chronic kidney disease.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Ages 18-90
* Self-Identified as Black/African American. Race will be self-identified. Patients of African ancestry who identify as multi-racial are also eligible to participate.

Exclusion Criteria:

* Cognitively impaired/unable to provide consent
* Terminally ill
* Renal replacement therapy (RRT), e.g., (but not limited to) hemodialysis, peritoneal dialysis

Where it's running

• SSM Health Saint Louis University Hospital
  St Louis, Missouri, United States Recruiting

Study contacts

• Study coordinator: Krista Lentine, PhD, MD
• Email: krista.lentine@health.slu.edu
• Phone: 314-257-3760

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Clinical decision support to help consider SGLT2 inhibitors after AKI in type 2 diabetes

  This pilot test checks if a CDS message given to clinicians can help decide whether to consider SGLT2 inhibitors for adults with type 2 diabetes who recently had acute kidney injury.

  Recruiting University of Minnesota · Minneapolis, Minnesota · NCT07868666

• Impact of TAVR on kidney function in people with aortic valve disease

  This registry tests how trans-catheter aortic valve implantation affects kidney function and the risk of kidney injury in adults with aortic stenosis.

  Recruiting Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Roma, RM · NCT07626710

• Calciphylaxis in people with chronic kidney disease: causes, risks, and early signs

  This project will compare adults with chronic kidney disease who develop calciphylaxis to matched CKD patients who do not, collecting clinical data and biological samples to try to find risk factors and early signs.

  Recruiting Odense University Hospital · Odense · NCT07511283

• Transition outcomes for adolescents and young adults with a cancer predisposition.

  See if young adults with a genetic cancer predisposition establish and keep up care with adult providers and follow recommended cancer surveillance after they leave pediatric care at St. Jude.

  Recruiting St. Jude Children's Research Hospital · Memphis, Tennessee · NCT07456904

• Oral Semaglutide for CKD and MAFLD in adults with diabetes

  This study tests whether adding oral semaglutide to standard care can slow kidney and liver disease progression in adults with CKD and MAFLD who have type 2 diabetes.

  Recruiting Institute of Liver and Biliary Sciences, India · New Delhi, National Capital Territory of Delhi · NCT07391267

• Eye-brain-kidney connections in chronic kidney disease

  This study will see if changes in brain network connectivity and retinal blood vessels are linked to cognitive decline and kidney function in adults with chronic kidney disease.

  Recruiting Beijing Friendship Hospital · Beijing, Beijing Municipality · NCT07358572

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.